x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The Lumara Series

A Genflare-produced Podcast Series.Series Title: The Lumara Series: A Competitive Intelligence Podcast for Market Access and Brand Leaders in Specialty PharmaSeries Overview:The Lumara Series is an 8-episode, TA-specific competitive intelligence podcast produced by Genflare using commercially available GenAI tooling and systems to both generate all of the underlying content and sciences as well as the 2-speaker (podcast format) audio files that make up each of the episodes in the series. The series

business management

All Episodes

8:25

Episode 8: Launching Lumara –– What Success Could...

The Lumara Series ·

2025/11/24

Launching Lumara — What Success Could Look Like Episode 8 brings the series together with a pragmatic launch integration plan: how a specialty biologic turns strategy into day-one execution. We outline the success factors that consistently separate winners: clear, payer-oriented messaging; layered evidence with early RWE; real-time competitive response; cross-TA access innovation; and tight alignment across Access, HEOR, Medical, and Field. You’ll hear how Lumara’s team pressure-tests readine...

en-us

13:59

Episode 7: Lessons from Elsewhere — What Other TAs...

The Lumara Series ·

2025/11/16

Lessons from Elsewhere — What Other TAs Are Doing Better Episode 7 looks outside severe asthma to borrow what works in oncology, migraine, and rare disease—and translate those access innovations to Lumara’s launch. We break down biomarker-tiered approaches and predictive outcome modeling from oncology; responder-based, modular reimbursement and pharmacy-channel starter kits from migraine; and concierge-style support with seamless financial triage from rare diseases. Then we map what’s portabl...

en-us

11:37

Episode 6: The Unknown Unknowns -- How Much Intel Are...

The Lumara Series ·

2025/11/10

The Unknown Unknowns — How Much Intel Are Your Competitors Gathering? Episode 6 pulls back the curtain on competitive intelligence (CI) maturity in severe asthma launches—what top teams track, how fast they learn, and why it matters for pricing, access, messaging, and patient support. We contrast integrated, always-on CI programs with reactive, vendor-only approaches, and show how social listening, field feedback loops, KOL digital patterns, and payer advisory monitoring translate into real d...

en-us

9:26

Episode 5: Scaling the Access Wall –– Real-World...

The Lumara Series ·

2025/11/03

Episode 5: Scaling the Access Wall — Real-World Evidence as a Differentiator In episode 5, we explore how real-world evidence (RWE) has become the currency of access decisions. Beyond trials, payers want proof in routine care—on exacerbations, persistence, and healthcare utilization—and they use it for formulary positioning and renewal negotiations. We compare how leading severe-asthma brands deploy RWE today (e.g., registry analyses, integrated claims/EMR studies, regional dashboards) and ou...

en-us

15:21

Episode 4: Message Battles –– What Are Competitors...

The Lumara Series ·

2025/10/28

Purpose of Episode: In Episode 4 we'll explore how existing brands in the Severe Asthma market are positioning their value stories to payers — in both economic and clinical terms. The episode will examine the structure, tone, and content of competitor access messaging, including AMCP dossiers, value decks, and in-field conversations. Lumara’s team must develop a differentiated and credible payer narrative — one that can cut through entrenched positioning and resonate with pharmacy and medical...

en-us

14:01

Episode 3: Patient Support Showdown –– HUBs, Copays,...

The Lumara Series ·

2025/10/20

Patient Support Showdown — HUBs, Copays, and Frictionless Starts Episode 3 zeroes in on the first-fill moment and early adherence—where HUB design, copay policy, and specialty-pharmacy handoffs can make or break momentum. We unpack the essentials of high-performing programs (benefits investigation, real-time PA tracking, FRM support, nurse case management, and digital enrollment) and spotlight where patients and offices most often stall. You’ll hear how leading severe-asthma brands appr...

en-us

11:48

Episode 2: The Coverage Chessboard

The Lumara Series ·

2025/10/13

The Coverage Chessboard — Formulary Status and Rebate Wars Episode 2 dives into the real engine of access: how plans decide who gets preferred, who gets blocked, and what it really costs to move tiers. We unpack the payer dynamics shaping severe asthma today—tiering norms, step edits, and prior auth criteria—then walk through what wins preferred placement: net price after rebates, label breadth and real-world outcomes, ease of administration, and the quality of patient services. You’ll also h...

en-us

17:29

Episode 1: Meet Lumara

The Lumara Series ·

2025/10/02

Meet Lumara: A New Contender in Severe Asthma In Episode 1, we introduce Lumara—a fictional, once-monthly biologic with dual IL-5 and IL-13 inhibition—poised to enter a crowded severe-asthma market. With launch roughly 12 months out, early conversations with payers and providers have begun, and the competitive set—Dupixent, Fasenra, Tezspire, Nucala—is well established. We frame the stakes, surface emerging access vulnerabilities, and set the tone for an eight-part, intelligence-driven series...

en-us

3:27

Lumara Series Trailer: A GenAI-generated Podcast...

The Lumara Series ·

2025/09/10

A Genflare-produced Podcast Series. Series Title: The Lumara Series: A Competitive Intelligence Podcast for Market Access and Brand Leaders in Specialty Pharma Series Overview: The Lumara Series is an 8-episode, TA-specific competitive intelligence podcast produced by Genflare using commercially available GenAI tooling and systems to both generate all of the underlying content and sciences as well as the 2-speaker (podcast format) audio files that make up each of the episodes in the ser...

en-us

9 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...